Trial
NCT00100828
Irinotecan in Treating Patients With Metastatic or Inoperable Thyroid Cancer
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
National Cancer Institute (NCI)
Condition
Head and Neck Cancer
Intervention
irinotecan hydrochloride
Why stopped
Closed due to early stopping rule
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-12-06